Yoshiyuki Abe
Overview
Explore the profile of Yoshiyuki Abe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawamori K, Oguro N, Shimizu K, Kida T, Omura S, Nakagomi D, et al.
Mod Rheumatol
. 2025 Jan;
PMID: 39887020
Objectives: Cytomegalovirus (CMV) reactivation during immunosuppressive therapy poses a risk of severe infections. This study aimed to investigate the risk factors of CMV reactivation in patients with microscopic polyangiitis and...
2.
Ogita C, Noguchi K, Takeuchi J, Azuma N, Omura S, Nakagomi D, et al.
Immunol Med
. 2025 Jan;
1-8.
PMID: 39797708
Rituximab (RTX) has been reported to effectively maintain remission in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). In this multicenter study involving 57 patients who achieved remission after 24 weeks, we evaluated...
3.
Nishioka R, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, et al.
Mod Rheumatol
. 2024 Dec;
PMID: 39716472
Objective: To assess the prevalence and outcomes among regimens of glucocorticoid tapering for microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) in real-world practice. Methods: We retrospectively examined the Japan...
4.
Abe Y, Kogami M, Ando T, Makiyama A, Asanuma Y, Yamaji K, et al.
Int J Rheum Dis
. 2024 Sep;
27(9):e15338.
PMID: 39291720
No abstract available.
5.
Kidoguchi G, Yoshida Y, Watanabe H, Sugimoto T, Mokuda S, Kida T, et al.
Clin Rheumatol
. 2024 Aug;
43(10):3195-3204.
PMID: 39134873
We aimed to clarify the long-term safety and efficacy of rituximab (RTX) as a remission induction therapy following severe relapse in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We...
6.
Miyamae T, Manabe Y, Sugihara T, Umezawa N, Yoshifuji H, Tamura N, et al.
Mod Rheumatol
. 2024 Aug;
35(2):339-344.
PMID: 39116014
Objectives: This study aimed to understand the status quo of medical treatments and pregnancy outcomes in patients with Takayasu arteritis (TAK) and children's birth outcomes. Methods: This study retrospectively enrolled...
7.
Omura S, Kida T, Noma H, Inoue H, Sofue H, Sakashita A, et al.
Rheumatology (Oxford)
. 2024 Apr;
63(9):2484-2493.
PMID: 38608193
Objectives: To evaluate the effectiveness and safety of two different intravenous methylprednisolone (IVMP) pulse doses in patients with severe microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). Methods: We emulated...
8.
Abe Y, Fujii T, Miyawaki Y, Sugihara T, Uchida H, Maejima Y, et al.
Mod Rheumatol
. 2024 Apr;
34(6):1194-1201.
PMID: 38590042
Objectives: The aim is to access the real-world clinical management of physicians who treat Takayasu arteritis (TAK) and giant cell arteritis (GCA) after the publication of the Japanese Circulation Society...
9.
Karadag O, Bolek E, Ayan G, Mohammad A, Grayson P, Pagnoux C, et al.
Arthritis Rheumatol
. 2024 Feb;
76(7):1120-1129.
PMID: 38343337
Objective: We describe the demographics, clinical features, disease course, and survival of polyarteritis nodosa (PAN) through an international collaboration (GLOBAL-PAN). Methods: Patients with PAN were recruited between 1990 and 2020...
10.
Ando T, Abe Y, Yamaji K, Nishikomori R, Tamura N
Mod Rheumatol Case Rep
. 2023 Nov;
8(2):368-372.
PMID: 38036300
Cryopyrin-associated periotic syndrome (CAPS) is a rare autoinflammatory disease caused by genetic variants in innate immunity genes. Autoinflammatory diseases, including CAPS, mediate proinflammatory cytokines such as interleukin (IL)-1 and IL-18...